Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes

BACKGROUND: Limited efficacy of IV recombinant tissue plasminogen activator (rt-PA) for large vessel occlusions (LVO) raises doubts about its utility prior to endovascular therapy. PURPOSE: To compare outcomes and hospital costs for anterior circulation LVOs (middle cerebral artery, internal carotid...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Ansaar T, Boo, SoHyun, Buseman, Chelsea, Adcock, Amelia K, Tarabishy, Abdul R, Miller, Maurice M, Roberts, Thomas D, Domico, Jennifer R, Carpenter, Jeffrey S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Ischemic Stroke
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749313/
https://www.ncbi.nlm.nih.gov/pubmed/28062805
http://dx.doi.org/10.1136/neurintsurg-2016-012830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749313/
https://www.ncbi.nlm.nih.gov/pubmed/28062805
http://dx.doi.org/10.1136/neurintsurg-2016-012830

Ejemplares similares